SCHEMBL7020196

SCHEMBL7020196

CCOC(=O)c1cnc2ccc(Cl)cc2c1.O=C(O)c1cnc2ccc(Cl)cc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.55
CYP2C19 P33261 3/20 0.55
MAOB P27338 5/20 0.53
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
MGAM O43451 1/20 0.47
SIRT2 Q8IXJ6 1/20 0.46
SIRT1 Q96EB6 1/20 0.46
SIRT3 Q9NTG7 1/20 0.46
ALDH1A1 P00352 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPK10 P53779 1/20 0.45
PDGFRB P09619 1/20 0.45
PDGFRA P16234 1/20 0.45
CYP1A2 P05177 3/20 0.44
MAPT P10636 1/20 0.44
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4398696 0.95 MAOB (0.56) CYP2C9CYP2C19MAOBNPC1RAB9A
SCHEMBL2306751 0.85 MGAM (0.62) CYP2C9MGAMALDH1A1POLBALOX15
SCHEMBL2204650 0.84 MAOB (0.65) CYP2C9CYP2C19MAOBNPC1RAB9A
SCHEMBL29793278 0.80 MAOB (0.56) CYP2C9CYP2C19MAOBNPC1RAB9A
SCHEMBL26680685 0.80 MAOB (0.56) CYP2C9CYP2C19MAOBNPC1RAB9A
SCHEMBL29940590 0.80 RXFP1 (0.53) L3MBTL1MAPTKDM4EPOLBALOX15
SCHEMBL846386 0.79 TSHR (0.61) CYP2C9CYP2C19MAOBNPC1RAB9A
SCHEMBL26798599 0.79 LMNA (0.54) CYP2C9CYP2C19MAOBNPC1RAB9A
SCHEMBL2205670 0.79 ALDH1A1 (0.52) CYP2C9CYP2C19MAOBNPC1RAB9A
SCHEMBL26681960 0.79 MAOB (0.61) CYP2C9CYP2C19MAOBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296972-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS Aventis Pharmaceuticals Inc. (US) 2003-04-02 EP disclosed
WO-2001090101-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2001-11-29 WO disclosed